Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Mar 2024. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5308699017 | Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5308700016 | Aluminum hydroxide 35 mg/mL and magnesium hydroxide 40 mg/mL and simethicone 5 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5308701017 | Aluminium hydroxide 35 mg/mL and magnesium hydroxide 40 mg/mL and simeticone 5 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Aluminium hydroxide and magnesium hydroxide and simeticone only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral suspension | true | Inferred relationship | Some | ||
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Plays role | Laxative therapeutic role | false | Inferred relationship | Some | ||
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Aluminium hydroxide | true | Inferred relationship | Some | 1 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Aluminium hydroxide | true | Inferred relationship | Some | 1 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Magnesium hydroxide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Magnesium hydroxide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Simeticone | true | Inferred relationship | Some | 3 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Simeticone | true | Inferred relationship | Some | 3 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
| Product containing precisely aluminium hydroxide 35 milligram/1 milliliter and magnesium hydroxide 40 milligram/1 milliliter and simeticone 5 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR